Milwaukee Campus-Children's Wisconsin
8915 W Connell Ave, 
Milwaukee, WI 

Overview

Peter Shaw is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin.

His clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Histiocytosis, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 25 peer reviewed articles and participating in 18 clinical trials.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in WI

Hospital Affiliations

Childrens Hospital Of Wisconsin

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Children's Community Health
  • EPO
  • PPO
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 6 Less Insurance Carriers -

Locations

Milwaukee Campus-Children's Wisconsin
8915 W Connell Ave, Milwaukee, WI 53226

Additional Areas of Focus

Dr. Shaw has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC# 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Key Adverse Events After Childhood Cancer
View 6 Less Clinical Trials
Similar Doctors
Expertise in
3
conditions
Hematology | Oncology
Expertise in
3
conditions
Hematology | Oncology
Referral may be required

Childrens Hospital Of Wisconsin Inc

8915 W Connell Ave, 
Milwaukee, WI 
 (0.3 miles away)
Languages Spoken:
English

Robert Montgomery is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Montgomery is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, Hemophilia B, and Bone Marrow Transplant.

Expertise in
15
conditions
Hematology | Oncology
Expertise in
15
conditions
Hematology | Oncology
Referral may be required

Clinical Cancer Center - Froedtert Hospital

8800 W. Doyne Ave., 
Milwaukee, WI 
 (0.1 miles away)
Languages Spoken:
English, Hindi
Accepting New Patients
Offers Telehealth

Dr. Anita D’Souza is a professor of medicine (hematology/oncology). She completed her medical school from Goa Medical College, India where she graduated at the top of her class and was awarded Best Medical Graduate. She completed her internal medicine residency from William Beaumont Hospital in Michigan where she received the Zimmerman Award for Outstanding Clinical Judgment, Leadership, and Integrity. She completed her hematology/oncology fellowship from the Mayo Clinic in Rochester, Minnesota. She is a past recipient of the Daniel McCarty Award for Research Excellent and Women in Science Rising Pioneer Award at MCW. Dr. D'souza is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. D'souza is board certified in Internal Medicine and Medical Oncology And Hematology. Dr. D'souza is currently accepting new patients.

Expertise in
11
conditions
Hematology | Oncology
Expertise in
11
conditions
Hematology | Oncology
Referral may be required

Clinical Cancer Center - Froedtert Hospital

8800 W. Doyne Ave., 
Milwaukee, WI 
 (0.1 miles away)
Languages Spoken:
English, Hindi, Nepali
Accepting New Patients
Offers Telehealth

Binod Dhakal, MD, MS, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed internal medicine residency at Saint Francis Hospital, Evanston, IL, and a fellowship in hematology/oncology at the Medical College of Wisconsin, where he also served as a chief fellow. Prior to joining the fellowship, he was an assistant professor of medicine (general internal medicine) at the Medical College in Wisconsin. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; Medical College of Wisconsin Affiliated Hospitals (MCWAH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science. His current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials. Dr. Dhakal is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dhakal is currently accepting new patients.

Frequently Asked Questions about Dr. Peter Shaw

How do I make an appointment with Dr. Peter Shaw?

You can book an appointment with Dr. Peter Shaw by calling their office at 414-266-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Peter Shaw a top-rated expert for Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peter Shaw is classified as an Experienced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Peter Shaw specialize in?

While Dr. Peter Shaw is a Hematology, they have specific expertise in Leukemia, Acute Lymphoblastic Leukemia (ALL), and Langerhans Cell Histiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Peter Shaw participate in research or clinical trials?

Yes. Dr. Peter Shaw has published 25 articles and abstracts on conditions like Leukemia. You can view a list of Dr. Peter Shaw's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Peter Shaw accept my insurance?

Dr. Peter Shaw accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health. We recommend calling the office directly at 414-266-2000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shaw's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile